Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Solenthaler

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Hematology|August 6, 2011
Pyrazinamide-induced sideroblastic anemiaGiuseppe Colucci, Tobias Silzle, Max Solenthaler
European Journal of Gastroenterology & Hepatology|September 23, 2003
Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two casesJohanna A Kremer Hovinga, Max Solenthaler, Jean-François Dufour
Haematologica|November 5, 2002
p53 and mdm2 in mantle cell lymphoma in leukemic phaseMax Solenthaler, Estella Matutes, Vasantha Brito-Babapulle, et al.
Blood|May 8, 2009
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progressionSabine Mumprecht, Christian Schürch, Juerg Schwaller, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trialAntonello Calderoni, Christian von Briel, Stefan Aebi, et al.
Hematological Oncology|June 5, 2018
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expressionAlexandra Junge, Ulrike Bacher, Beatrice U Mueller, et al.
Annals of Hematology|April 1, 2009
Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemiaHermann Heimpel, Ulrich Dührsen, P Hofbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Risk assessment in patients with acute myeloid leukemia and a normal karyotypeMarianne Bienz, Madleina Ludwig, Elisabeth Oppliger Leibundgut, et al.
Leukemia & Lymphoma|January 20, 2009
Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95Reinhard Zenhäusern, Albert Von Rohr, Kaspar Rufibach, et al.
Haematologica|March 17, 2004
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpuraJohanna A Kremer Hovinga, Jan-Dirk Studt, Franziska Demarmels Biasiutti, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Hematology|August 6, 2011
Pyrazinamide-induced sideroblastic anemiaGiuseppe Colucci, Tobias Silzle, Max Solenthaler
European Journal of Gastroenterology & Hepatology|September 23, 2003
Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two casesJohanna A Kremer Hovinga, Max Solenthaler, Jean-François Dufour
Haematologica|November 5, 2002
p53 and mdm2 in mantle cell lymphoma in leukemic phaseMax Solenthaler, Estella Matutes, Vasantha Brito-Babapulle, et al.
Blood|May 8, 2009
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progressionSabine Mumprecht, Christian Schürch, Juerg Schwaller, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trialAntonello Calderoni, Christian von Briel, Stefan Aebi, et al.
Hematological Oncology|June 5, 2018
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expressionAlexandra Junge, Ulrike Bacher, Beatrice U Mueller, et al.
Annals of Hematology|April 1, 2009
Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemiaHermann Heimpel, Ulrich Dührsen, P Hofbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Risk assessment in patients with acute myeloid leukemia and a normal karyotypeMarianne Bienz, Madleina Ludwig, Elisabeth Oppliger Leibundgut, et al.
Leukemia & Lymphoma|January 20, 2009
Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95Reinhard Zenhäusern, Albert Von Rohr, Kaspar Rufibach, et al.
Haematologica|March 17, 2004
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpuraJohanna A Kremer Hovinga, Jan-Dirk Studt, Franziska Demarmels Biasiutti, et al.
Pageof 2